Identification of a nanobody specific to human pulmonary surfactant protein A. - Wikidata - awgldk - TriplyDB

Identification of a nanobody specific to human pulmonary surfactant protein A.

Identification of a nanobody specific to human pulmonary surfactant protein A.

http://www.wikidata.org/entity/Q33684637

about

Erratum: Identification of a nanobody specific to a human pulmonary surfactant protein A.

P921

Q42365549-EFD4FAE6-E1E1-42D7-B1DE-A8F299970085

P921

Identification of a nanobody specific to human pulmonary surfactant protein A.

http://www.wikidata.org/entity/Q33684637

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Identification of a nanobody specific to human pulmonary surfactant protein A.

@ast

Identification of a nanobody specific to human pulmonary surfactant protein A.

@en

type

label

Identification of a nanobody specific to human pulmonary surfactant protein A.

@ast

Identification of a nanobody specific to human pulmonary surfactant protein A.

@en

prefLabel

Identification of a nanobody specific to human pulmonary surfactant protein A.

@ast

Identification of a nanobody specific to human pulmonary surfactant protein A.

@en

P1433

Q33684637-86AF0156-3C97-4CC2-A60C-7FFA51911690

P1476

Q33684637-34DC5814-D164-4964-86ED-45FB5BFF5490

P2093

Q33684637-26CF9D9C-E6BE-4403-BC1F-AB29FC5CD2B1

Q33684637-322C440F-F1B0-4F7A-AA2B-E820580B810D

Q33684637-4B3D579D-5978-48A9-A83A-8E3E1C4FE04D

Q33684637-4F9AA3AF-EEBA-44F5-BFD6-D5152C6117CE

Q33684637-72F2AC3B-B133-4037-89C0-134FF56B8479

Q33684637-7492C885-F981-42C2-81E0-F651A3A43448

Q33684637-74CA9DDF-A7E6-432C-B205-0199C4F79384

Q33684637-7915B450-28DC-4C8C-956D-9EC6A922ADED

Q33684637-A1C81FB3-0691-4CA1-BC17-24BEEBDFC397

Q33684637-A68B828C-CBA1-4C60-870C-D9BBEED2CC19

P2507

Q33684637-D06470A3-2529-4587-91EF-A9416C857DD0

P2860

Q33684637-04C21002-6922-488D-B01C-A2722602BDEF

Q33684637-13A940D2-FF60-4684-929A-18DFF9081730

Q33684637-1564700F-98EA-4AE4-8156-0367B829D861

Q33684637-1CDDBD9B-B49C-4788-9704-1CB01BA1C208

Q33684637-29F4BE26-924C-4C29-86B3-0ECD28DA0292

Q33684637-2EACF8EA-C002-403B-82AF-E173B6E3C00D

Q33684637-41CEEB34-7B33-449E-B03C-EDDF778FAF85

Q33684637-5CA0655D-A724-403A-B7D9-7B1A72AA9ABF

Q33684637-64F8C350-B1DE-488B-B4F2-A66F570C4F16

Q33684637-80B86AF0-D0A5-42A9-9B15-AEE926027369

P2888

Q33684637-D7F3A3B0-65EC-4746-9319-EAE55B010F68

P304

Q33684637-7A8DC114-34E2-4EE9-B808-2D3205CA6F5D

P31

Q33684637-DD3B6D5D-ADE8-4AA2-8A8F-19408885942E

P356

Q33684637-36033D96-D733-49BF-AADF-5410A9970E0C

P407

Q33684637-C37EA871-62EF-4E8D-8D9B-3AF539519F2A

P433

Q33684637-F327C499-C9E8-4DE3-9975-DBA1D6C2CBEF

P478

Q33684637-A983522A-0F43-483E-8B81-04C9829D4CEF

P577

Q33684637-EFF140EC-9967-4F76-8F83-79068F65667D

P6179

Q33684637-8A5D5A2D-C5A5-4FE2-84D6-373D6B1BFDD0

P698

Q33684637-A1545B25-7CC0-4F83-B4DF-2491CFF2B0E9

P932

Q33684637-D192F2ED-D3B8-40B4-B7E7-3D13FC7A354F

P356

S41598-017-01456-2

P1433

Scientific Reports

P1476

Identification of a nanobody specific to human pulmonary surfactant protein A.

@en

P2093

Dong Weng

http://www.w3.org/2001/XMLSchema#string

Feng Yu

http://www.w3.org/2001/XMLSchema#string

Hui-Ping Li

http://www.w3.org/2001/XMLSchema#string

Jian-Hua He

http://www.w3.org/2001/XMLSchema#string

Liu-Sheng Wang

http://www.w3.org/2001/XMLSchema#string

Meng-Meng Zhao

http://www.w3.org/2001/XMLSchema#string

Nan Li

http://www.w3.org/2001/XMLSchema#string

Shan-Mei Wang

http://www.w3.org/2001/XMLSchema#string

Shan-Shan Chen

http://www.w3.org/2001/XMLSchema#string

Shan-Shan Du

http://www.w3.org/2001/XMLSchema#string

P2507

Erratum: Identification of a nanobody specific to a human pulmonary surfactant protein A.

P2860

Surfactant protein A-binding proteins. Characterization and structures

Naturally occurring antibodies devoid of light chains

The effects of inhaled corticosteroids on growth in children.

Nanobody: the "magic bullet" for molecular imaging?

Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura.

Creation of lung-targeted dexamethasone immunoliposome and its therapeutic effect on bleomycin-induced lung injury in rats.

A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment.

A novel nanobody specific for respiratory surfactant protein A has potential for lung targeting.

Advanced targeted nanomedicine

Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection.

P2888

s41598-017-01456-2

P304

1412

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-01456-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085116444

http://www.w3.org/2001/XMLSchema#string

P698

28469136

http://www.w3.org/2001/XMLSchema#string

P932

5431231

http://www.w3.org/2001/XMLSchema#string